We proposed that elucidating the mechanisms underpinning the barrier-protective properties of HBD2, against V8, could inform future therapeutic and/or preventative strategies for AD and other chronic inflammatory skin diseases. The gene discussed is DEFB4A; the disease is Alzheimer disease.